AR031348A1 - Inhalacion de oxido nitrico - Google Patents

Inhalacion de oxido nitrico

Info

Publication number
AR031348A1
AR031348A1 ARP010105331A ARP010105331A AR031348A1 AR 031348 A1 AR031348 A1 AR 031348A1 AR P010105331 A ARP010105331 A AR P010105331A AR P010105331 A ARP010105331 A AR P010105331A AR 031348 A1 AR031348 A1 AR 031348A1
Authority
AR
Argentina
Prior art keywords
nitric oxide
treatment
constriction
combination
pulmonary vasoconstriction
Prior art date
Application number
ARP010105331A
Other languages
English (en)
Original Assignee
Aga As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga As filed Critical Aga As
Publication of AR031348A1 publication Critical patent/AR031348A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El uso de oxido nítrico inhalable (NO) en combinacion con un inhibidor de la ciclooxigenasa para la elaboracion de un medicamento para el tratamiento de la vasoconstriccion pulmonar o la constriccion de las vías respiratorias en un mamífero incluso en el hombre, a fin de contrarrestar una respuesta escasa o nula al tratamiento con oxido nítrico gaseoso o donador de oxido nítrico solamente y/o para contrarrestar el efecto rebote en el caso de suspension del tratamiento con oxido nítrico gaseosos o donador de oxido nítrico solamente, combinacion que se utiliza en una cantidad terapéuticamente efectiva para lograr la relajacion de dicha vasoconstriccion pulmonar o constriccion de las vías respiratorias. Un método y una preparacion farmacéutica para el tratamiento de la vasoconstriccion pulmonar o constriccion de las vías respiratorias utilizando la combinacion antes mencionada.
ARP010105331A 2000-11-17 2001-11-15 Inhalacion de oxido nitrico AR031348A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide

Publications (1)

Publication Number Publication Date
AR031348A1 true AR031348A1 (es) 2003-09-17

Family

ID=20281873

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105331A AR031348A1 (es) 2000-11-17 2001-11-15 Inhalacion de oxido nitrico

Country Status (19)

Country Link
US (1) US20040028753A1 (es)
EP (1) EP1339428B1 (es)
JP (1) JP2004513928A (es)
CN (1) CN100443119C (es)
AR (1) AR031348A1 (es)
AT (1) ATE354375T1 (es)
AU (2) AU1451902A (es)
CA (1) CA2429224A1 (es)
CZ (1) CZ20031617A3 (es)
DE (1) DE60126814T2 (es)
EE (1) EE200300226A (es)
ES (1) ES2282310T3 (es)
IL (1) IL155968A0 (es)
NZ (1) NZ526295A (es)
PL (1) PL362023A1 (es)
SE (1) SE0004229D0 (es)
SK (1) SK7312003A3 (es)
WO (1) WO2002040052A1 (es)
ZA (1) ZA200303845B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7049326B2 (en) 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
EP1400243A1 (en) * 2002-09-19 2004-03-24 Tanabe Seiyaku Co., Ltd. Calcium-activated K channel activator
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
DK176782B1 (da) * 2006-08-04 2009-08-17 Innovision As Fremgangsmåde til at kompensere for effekten af recirkulation af blodoplöselig gas på bestemmelse af pulmonal blodgennemströmning i gentagne tests med genånding af inert gas
ES2768250T5 (es) 2011-10-03 2023-12-21 Nitricgen Inc Aparato y método para generar óxido nítrico en cantidades controladas y precisas
WO2013132503A1 (en) * 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CN109663193A (zh) 2013-03-15 2019-04-23 通用医疗公司 供吸入的一氧化氮气体的合成
BR112015022468B1 (pt) 2013-03-15 2022-11-01 The General Hospital Corporation Aparelho e método para síntese do gás óxido nítrico para inalação
KR20170072293A (ko) 2014-10-20 2017-06-26 더 제너럴 하스피탈 코포레이션 산화질소의 합성을 위한 시스템 및 방법
CN109310842B (zh) 2016-03-25 2022-08-19 通用医疗公司 用于电等离子体合成一氧化氮的输送系统和方法
KR20220137155A (ko) 2017-02-27 2022-10-11 써드 폴, 아이엔씨. 산화질소의 이동식 생성을 위한 시스템 및 방법
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
JP6704094B2 (ja) 2017-02-27 2020-06-03 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素を生成するためのシステムおよび方法
MX2019011432A (es) 2017-03-31 2020-01-20 Massachusetts Gen Hospital Sistemas y metodos para un generador de oxido nitrico enfriado.
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
JP2022532654A (ja) 2019-05-15 2022-07-15 サード ポール，インコーポレイテッド 一酸化窒素を生成するシステム及び方法
WO2021142472A1 (en) 2020-01-11 2021-07-15 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
WO2021258025A1 (en) 2020-06-18 2021-12-23 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
CN117440812A (zh) * 2021-05-11 2024-01-23 法尔麦兹公司 用于治疗冠状病毒病(covid-19)中的急性呼吸窘迫综合征(ards)的药物组合物及方法
EP4405019A1 (en) 2021-09-23 2024-07-31 Third Pole, Inc. Systems and methods for delivering nitric oxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537906A (en) * 1982-12-06 1985-08-27 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
US4536515A (en) * 1982-12-06 1985-08-20 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
DE122008000012I2 (de) * 1990-12-05 2012-04-12 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefassverengung und von Asthma.
US6649629B2 (en) * 1999-12-23 2003-11-18 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

Also Published As

Publication number Publication date
ATE354375T1 (de) 2007-03-15
WO2002040052A1 (en) 2002-05-23
CZ20031617A3 (cs) 2004-02-18
ES2282310T3 (es) 2007-10-16
JP2004513928A (ja) 2004-05-13
EP1339428A1 (en) 2003-09-03
ZA200303845B (en) 2004-09-09
CN1481256A (zh) 2004-03-10
US20040028753A1 (en) 2004-02-12
IL155968A0 (en) 2003-12-23
SE0004229D0 (sv) 2000-11-17
CA2429224A1 (en) 2002-05-23
DE60126814T2 (de) 2007-10-25
CN100443119C (zh) 2008-12-17
EE200300226A (et) 2003-08-15
NZ526295A (en) 2004-10-29
SK7312003A3 (en) 2004-02-03
PL362023A1 (en) 2004-10-18
EP1339428B1 (en) 2007-02-21
DE60126814D1 (de) 2007-04-05
AU2002214519B2 (en) 2004-08-12
AU1451902A (en) 2002-05-27

Similar Documents

Publication Publication Date Title
AR031348A1 (es) Inhalacion de oxido nitrico
CY1117571T1 (el) Συνδυασμος αντιχολινεργικων και ανταγωνιστων υποδοχεα λευκοτριενιου για την αγωγη αναπνευστικων νοσηματων
ES2178943B1 (es) Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica.
ES2173947T3 (es) Uso de furoato de mometasona para tratar enfermedades pulmonares y de las vias aereas.
UY26959A1 (es) Nuevos polvos para inhalación que contienen tiotropio
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
PT1326595E (pt) Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios
DE60216588D1 (de) Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
CR7152A (es) Un inhibidor de pde4 y un agente de anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias.
CL2011000710A1 (es) Combinacion farmaceutica que comprende un inhibidor especifico de smoothened y un inhibidor de cinasa pi3 especifico; y uso en el tratamiento de cancer.
MXPA05010402A (es) Oxido nitrico en el tratamiento de la inflamacion.
PE20191240A1 (es) Formas de administracion farmaceutica que contienen inhibidores de canales task-1 y task-3 y su uso para el tratamiento de trastornos respiratorios
CY1106845T1 (el) Χρηση της φλουμαζενιλης για την παρασκευη ενος φαρμακου για την αγωγη της εξαρτησεως απο την κοκαϊνη
BR0208305A (pt) Agonistas do receptor nicotìnico para o tratamento de doenças inflamatórias
UY30935A1 (es) Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones.
EA201170405A1 (ru) Монотерпены для лечения заболеваний дыхательных путей, в частности, бронхолегочных заболеваний
NO20073909L (no) Forstover-formulering
HUP0002859A2 (hu) A nitrogén-monoxidot kibocsátó vegyületek alkalmazása rinovírus-fertőzés által előidézett kórtünetek enyhítésére
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
AR038042A1 (es) Metodos y composiciones para el tratamiento de patologias respiratorias
CN202620408U (zh) 吸盐器
CN202777344U (zh) 结构改进的吸盐器
SE9903985D0 (sv) Use of nitric oxide
Susaman et al. Common Cold in Children 36
Liu Five supplementary therapies for COVID-19

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FA Abandonment or withdrawal